Veeva Systems Inc. (NYSE:VEEV), with significant hedge fund interests, is among the 10 Best SaaS Stocks to Buy According to Hedge Funds. In the first quarter of 2026, 62 hedge funds held bullish positions in the stock, representing $2.95 billion in added value, according to data from Insider Monkey.
This week, Veeva Systems Inc. (NYSE:VEEV) is accelerating its efforts to deepen its presence in the life sciences industry, securing major global CRM engagements while deploying new AI-powered automation tools for drug development. On May 28, 2026, Veeva Systems Inc. (NYSE:VEEV) announced that Kindeva, a contract development and manufacturing organization, will adopt Veeva Quality Cloud to unify its global network of sites on a single platform. The implementation includes Veeva QualityDocs, Veeva QMS, Veeva Training and Veeva LearnGxP. Kindeva said the platform will standardize training and quality assurance processes, eliminate data silos, and support growth across regions and therapeutic areas. That announcement followed a pair of CRM commitments disclosed on May 27, 2026. Merck KGaA (Darmstadt, Germany) made a global commitment to Veeva Vault CRM, with the company’s CIO citing consistent processes and data connectivity as priorities. On the same day, Teva Pharmaceuticals also committed to Vault CRM globally, with Teva stating that the platform will provide a technical foundation for business execution. Vault CRM is part of the broader Vault CRM suite from Veeva Systems Inc. (NYSE:VEEV) and includes artificial intelligence agents designed to drive business efficiency. Also on May 27, 2026, Veeva Systems Inc. (NYSE:VEEV) introduced Falcon, an agent platform built for drug development processes in life sciences. Falcon works with Veeva Development Cloud applications in clinical, regulatory and security functions. Initial focus areas include trial master file document intake, health authority correspondence, and security case triage. CEO Peter Gassner called it Veeva’s first offering in agency work, and availability to early users is planned for November 2026. Veeva Systems Inc. (NYSE:VEEV) is a provider of cloud-based solutions to the global life sciences industry. Its offerings include cloud software, artificial intelligence, data and business consulting. While we recognize VEEV’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock. READ NEXT: 33 stocks that should double in 3 years and 15 stocks that will make you rich in 10 years. Disclosure: None. Follow Insider Monkey on Google News.